KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Tax Provisions (2018 - 2025)

Historic Tax Provisions for Moderna (MRNA) over the last 8 years, with Q3 2025 value amounting to $13.0 million.

  • Moderna's Tax Provisions rose 6250.0% to $13.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.0 million, marking a year-over-year increase of 7131.78%. This contributed to the annual value of -$46.0 million for FY2024, which is 10595.85% down from last year.
  • Moderna's Tax Provisions amounted to $13.0 million in Q3 2025, which was up 6250.0% from $7.0 million recorded in Q2 2025.
  • Moderna's Tax Provisions' 5-year high stood at $1.7 billion during Q3 2023, with a 5-year trough of -$384.0 million in Q1 2023.
  • Moreover, its 5-year median value for Tax Provisions was $26.0 million (2021), whereas its average is $169.4 million.
  • Per our database at Business Quant, Moderna's Tax Provisions surged by 2700000.0% in 2021 and then crashed by 23321.3% in 2023.
  • Quarter analysis of 5 years shows Moderna's Tax Provisions stood at $542.0 million in 2021, then crashed by 64.94% to $190.0 million in 2022, then plummeted by 177.37% to -$147.0 million in 2023, then skyrocketed by 56.46% to -$64.0 million in 2024, then soared by 120.31% to $13.0 million in 2025.
  • Its last three reported values are $13.0 million in Q3 2025, $7.0 million for Q2 2025, and $7.0 million during Q1 2025.